Skip to main content
Log in

Operation innerhalb des ersten Jahres nach Drug-eluting-Stentimplantation – Risikoreich?

Surgery within the first year after implantation of drug-eluting stent – High risk?

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Kristensen SD, Knuuti J, Saraste A et al (2014) 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: the joint task force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 35(35):2383–2431

  2. Bønaa KH, Mannsverk J, Wiseth R et al (2016) Drug-eluting or bare-metal Stents for coronary artery disease. N Engl J Med 375(13):1242–1252

  3. Mehran R, Baber U, Steg PG et al (2013) Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 382(9906):1714–1722. doi:10.1016/s0140-6736(13)61720-1

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Eggebrecht.

Ethics declarations

Interessenkonflikt

H. Eggebrecht gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eggebrecht, H. Operation innerhalb des ersten Jahres nach Drug-eluting-Stentimplantation – Risikoreich?. Kardiologe 11, 155–156 (2017). https://doi.org/10.1007/s12181-017-0132-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-017-0132-6

Navigation